SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-20-271744
Filing Date
2020-10-19
Accepted
2020-10-19 09:27:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC14D9C d12457dsc14d9c.htm SC14D9C 10727
  Complete submission text file 0001193125-20-271744.txt   12246
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filed by) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-79091 | Film No.: 201245397
SIC: 2834 Pharmaceutical Preparations